GlassScriptPhysician profile
Diane R Krieger
NPI 1790757037
$2,786.18
in general payments reported to CMS, 2019-2025
19 companies · $305 in 2025
The $305 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $759 · 2020: $506 · 2021: $38.09 · 2022: $445 · 2023: $439 · 2024: $294 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,038.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,038.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $621.83 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Tandem Diabetes Care, INC. | $600.00 | 2019-2020 | |
| Insulet Corporation | $592.87 | 2019-2025 | Omnipod |
| Aytu Biopharma, INC. | $185.72 | 2019 | |
| Medtronic, INC. | $172.19 | 2021-2023 | Minimed 780g |
| Amgen INC. | $136.82 | 2020-2025 | Tepezza |
| Horizon Therapeutics Plc | $86.33 | 2019-2023 | Tepezza |
| Pfizer INC. | $59.98 | 2019-2020 | |
| Abbvie INC. | $41.18 | 2023-2025 | |
| Corcept Therapeutics | $39.87 | 2025 | Korlym |
| Novo Nordisk INC | $39.82 | 2024-2025 | Wegovy |
| Valeritas, INC. | $37.38 | 2019 | |
| Xeris Pharmaceuticals, INC. | $37.31 | 2022-2023 | Gvoke Hypopen |
| Janssen Pharmaceuticals, INC | $34.04 | 2019 | |
| Sequel Med Tech, LLC | $24.69 | 2025 | Twiist |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alvogen INC | $22.27 | 2022 | |
| Ascensia Diabetes Care US INC. | $18.93 | 2025 | |
| Cequr Corporation | $18.83 | 2024 | Cequr Simplicity |
| Intuity Medical INC | $16.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Krieger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.